Bank Julius Baer & Co. Ltd, Zurich Pacific Biosciences Of California, Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$24.86 - $35.02 $2 Million - $2.82 Million	-80,583 Closed	0 $0
Q2 2021 Jul 23, 2021	SELL	$22.3 - $36.02 $750,194 - $1.21 Million	-33,641 Reduced 29.45%	80,583 $2.82 Million
Q1 2021 May 10, 2021	SELL	$26.38 - $51.15 $2.65 Million - $5.13 Million	-100,348 Reduced 46.77%	114,224 $3.81 Million
Q4 2020 Feb 24, 2021	BUY	$10.5 - $28.5 $2.06 Million - $5.6 Million	196,594 Added 1093.53%	214,572 $5.57 Million
Q4 2020 Feb 12, 2021	BUY	$10.5 - $28.5 $188,769 - $512,373	17,978 New	17,978 $5.57 Million

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.